Want to become the sole advertiser on this website? Just £500 GBP / month.
Contact us today.
Short Interest Update GlobalBRVE

Braveheart Bio (BRVE) Short Interest Explodes to 632%

Braveheart Bio has seen a massive surge in short interest, with Ortex data indicating a jump to 632% of free float, up from 277% just one week ago.

Powered by NegativePublicRelations.com
By The Forensic Ledger Desk October 3, 20261 min read
Company
Braveheart Bio
Short % Float
632%
Days to Cover
0

Massive Short Interest Surge in BRVE

Braveheart Bio (BRVE) has become the center of intense short-selling activity. According to the latest data from Ortex, the company's short interest as a percentage of free float has skyrocketed to 632%, marking a 355-point increase in just seven days. This rapid accumulation of short positions suggests significant bearish conviction or a potential setup for extreme volatility.

Market Implications

Such elevated levels of short interest relative to the free float are rare and often indicate that the stock is becoming increasingly difficult to borrow. Investors should monitor for potential squeeze signals as the cost to maintain these positions likely rises in tandem with the scarcity of available shares. This data reflects near-real-time estimates from securities-lending markets, providing a much faster look at the situation than the stale bi-monthly exchange reports.

Source

Signal data sourced from Ortex. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.

#Short Interest#Biotech#Market Volatility

Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.

Commission a Report · The Forensic Ledger Desk

Forensic Research & Investigations

We conduct deep investigative research into publicly traded companies — deploying forensic accountants, field investigators, and industry experts to uncover business fraud (overstated revenues), accounting fraud (inflated profits), or severe fundamental business flaws.

Commission us to compose a short-seller research report on a company you target. Every dossier is built to evidentiary standards — sourced, falsifiable, and ready to move markets.

Commission a Report
Business Fraud

Overstated revenues, fake channels, pulled-forward demand.

Accounting Fraud

Inflated profits, aggressive recognition, hidden liabilities.

Fundamental Flaws

Structural business defects the market has mispriced.

The Negative PR Blog

The internet's leading source on negative PR campaigns, smear campaigns, bad press, and reputation warfare — real, recent events documented and dissected by our reporters, with expert analysis of how we'd respond.

Read the Blog